Disease of aging

Lewy Body Dementia

Last updated 2026-07-02· Last reviewed 2026-07-02· 1 min read

Reviewed by the Ultimate Longevity Bible editorial team. Educational reference — not medical advice. See disclaimer.

Distinguishing from Alzheimer's

LBD: fluctuating cognition, prominent visual hallucinations, parkinsonism, REM-sleep behaviour disorder.
Alzheimer's: prominent memory impairment early, less motor involvement.
Frequent co-occurrence with Alzheimer pathology in mixed dementia.

Diagnosis

Clinical criteria (McKeith et al.).
DAT-SPECT imaging shows reduced striatal dopamine transporter binding.
REM-sleep behaviour disorder is highly predictive when it precedes cognitive symptoms.

Management

Cognitive: rivastigmine (approved for PDD).
Motor: cautious levodopa titration; parkinsonism responds partially.
Behavioural: avoid typical antipsychotics — severe sensitivity with risk of neuroleptic malignant syndrome. Pimavanserin is the preferred antipsychotic when required.
Sleep: melatonin for RBD; clonazepam second-line.

Longevity relevance

Alpha-synuclein pathology is the shared substrate for Parkinson's disease and LBD — targeting synuclein aggregation is a major neurodegenerative-disease drug-development priority.